These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20382019)

  • 21. Liver X receptor-mediated induction of cholesteryl ester transfer protein expression is selectively impaired in inflammatory macrophages.
    Lakomy D; Rébé C; Sberna AL; Masson D; Gautier T; Chevriaux A; Raveneau M; Ogier N; Nguyen AT; Gambert P; Grober J; Bonnotte B; Solary E; Lagrost L
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1923-9. PubMed ID: 19679828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The discovery of tertiary-amine LXR agonists with potent cholesterol efflux activity in macrophages.
    Marino JP; Kallander LS; Ma C; Oh HJ; Lee D; Gaitanopoulos DE; Krawiec JA; Parks DJ; Webb CL; Ziegler K; Jaye M; Thompson SK
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5617-21. PubMed ID: 19717304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LXR{beta} is the dominant LXR subtype in skeletal muscle regulating lipogenesis and cholesterol efflux.
    Hessvik NP; Boekschoten MV; Baltzersen MA; Kersten S; Xu X; Andersén H; Rustan AC; Thoresen GH
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E602-13. PubMed ID: 19996385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-Aryl-N-acyl indole derivatives as liver X receptor (LXR) agonists.
    Kher S; Lake K; Sircar I; Pannala M; Bakir F; Zapf J; Xu K; Zhang SH; Liu J; Morera L; Sakurai N; Jack R; Cheng JF
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4442-6. PubMed ID: 17587573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Research progress of liver X receptor agonists].
    Liang Y; Guo CB; Zhang C; Hou ZG
    Yao Xue Xue Bao; 2012 Apr; 47(4):427-33. PubMed ID: 22799022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery and structure-guided optimization of tert-butyl 6-(phenoxymethyl)-3-(trifluoromethyl)benzoates as liver X receptor agonists.
    Matsui Y; Yamaguchi T; Yamazaki T; Yoshida M; Arai M; Terasaka N; Honzumi S; Wakabayashi K; Hayashi S; Nakai D; Hanzawa H; Tamaki K
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3914-20. PubMed ID: 26238323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).
    Li X; Yeh V; Molteni V
    Expert Opin Ther Pat; 2010 Apr; 20(4):535-62. PubMed ID: 20302451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and discovery of 2-oxochromene derivatives as liver X receptor β-selective agonists.
    Matsuda T; Okuda A; Watanabe Y; Miura T; Ozawa H; Tosaka A; Yamazaki K; Yamaguchi Y; Kurobuchi S; Koura M; Shibuya K
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1274-8. PubMed ID: 25677664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformationally-restricted cyclic sulfones as potent and selective mTOR kinase inhibitors.
    Liu KK; Bailey S; Dinh DM; Lam H; Li C; Wells PA; Yin MJ; Zou A
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5114-7. PubMed ID: 22765900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver.
    Anderson SP; Dunn C; Laughter A; Yoon L; Swanson C; Stulnig TM; Steffensen KR; Chandraratna RA; Gustafsson JA; Corton JC
    Mol Pharmacol; 2004 Dec; 66(6):1440-52. PubMed ID: 15371561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of a new binding mode for a series of liver X receptor agonists.
    Kopecky DJ; Jiao XY; Fisher B; McKendry S; Labelle M; Piper DE; Coward P; Shiau AK; Escaron P; Danao J; Chai A; Jaen J; Kayser F
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2407-10. PubMed ID: 22406115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery and Synthesis of a Novel Series of Liver X Receptor Antagonists.
    Nian S; Gan X; Tan X; Yu Z; Wang P; Chen X; Wang G
    Chem Pharm Bull (Tokyo); 2015; 63(8):628-35. PubMed ID: 26062802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver X receptor is a regulator of orphan nuclear receptor NOR-1 gene transcription in adipocytes.
    Kumar N; Wang H; Liu D; Collins S
    Int J Obes (Lond); 2009 May; 33(5):519-24. PubMed ID: 19238156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective activation of liver X receptors by acanthoic acid-related diterpenes.
    Traves PG; Hortelano S; Zeini M; Chao TH; Lam T; Neuteboom ST; Theodorakis EA; Palladino MA; Castrillo A; Bosca L
    Mol Pharmacol; 2007 Jun; 71(6):1545-53. PubMed ID: 17329499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver X receptor agonists inhibit tissue factor expression in macrophages.
    Terasaka N; Hiroshima A; Ariga A; Honzumi S; Koieyama T; Inaba T; Fujiwara T
    FEBS J; 2005 Mar; 272(6):1546-56. PubMed ID: 15752369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver X receptors: From pharmacology to nanoparticle-based drug delivery.
    Hua X; Wei X
    Eur J Pharmacol; 2023 Oct; 956():175953. PubMed ID: 37541371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alpha-hydroxylase (CYP7a).
    Menke JG; Macnaul KL; Hayes NS; Baffic J; Chao YS; Elbrecht A; Kelly LJ; Lam MH; Schmidt A; Sahoo S; Wang J; Wright SD; Xin P; Zhou G; Moller DE; Sparrow CP
    Endocrinology; 2002 Jul; 143(7):2548-58. PubMed ID: 12072387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and structure-activity relationship of podocarpic acid amides as liver X receptor agonists for potential treatment of atherosclerosis.
    Liu W; Chen S; Dropinski J; Colwell L; Robins M; Szymonifka M; Hayes N; Sharma N; MacNaul K; Hernandez M; Burton C; Sparrow CP; Menke JG; Singh SB
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4574-8. PubMed ID: 16125384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting selective liver X receptor β agonists using multiple machine learning methods.
    Li Y; Wang L; Liu Z; Li C; Xu J; Gu Q; Xu J
    Mol Biosyst; 2015 May; 11(5):1241-50. PubMed ID: 25734698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-dimensional pharmacophore modeling of liver-X receptor agonists.
    Zhao W; Gu Q; Wang L; Ge H; Li J; Xu J
    J Chem Inf Model; 2011 Sep; 51(9):2147-55. PubMed ID: 21434646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.